|
Symbol Name ID |
Slc22a3
solute carrier family 22 (organic cation transporter), member 3 MGI:1333817 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Slc22a3em1(IMPC)Mbp/Slc22a3em1(IMPC)Mbp C57BL/6N-Slc22a3em1(IMPC)Mbp/MbpMmucd |
abnormal behavior | J:211773 |
| abnormal eye morphology | J:211773 | |
| anophthalmia | J:211773 | |
| decreased anxiety-related response | J:211773 | |
| decreased thigmotaxis | J:211773 | |
| hyperactivity | J:211773 | |
| Slc22a3tm1Dpb/Slc22a3tm1Dpb involves: 129P2/OlaHsd |
abnormal dopamine level | J:180517 |
| increased susceptibility to dopaminergic neuron neurotoxicity | J:180517 | |
| Slc22a3tm1Dpb/Slc22a3tm1Dpb involves: 129P2/OlaHsd * FVB/N |
normal behavior/neurological phenotype | J:69978 |
| normal cardiovascular system phenotype | J:69978 | |
| normal growth/size/body region phenotype | J:69978 | |
| normal mortality/aging | J:69978 | |
| normal nervous system phenotype | J:69978 | |
| normal reproductive system phenotype | J:69978 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||